Bobrovs, R.; Kanepe, I.; Narvaiss, N.; Patetko, L.; Kalnins, G.; Sisovs, M.; Bula, A.L.; Grinberga, S.; Boroduskis, M.; Ramata-Stunda, A.;
et al. Discovery of SARS-CoV-2 Nsp14 and Nsp16 Methyltransferase Inhibitors by High-Throughput Virtual Screening. Pharmaceuticals 2021, 14, 1243.
https://doi.org/10.3390/ph14121243
AMA Style
Bobrovs R, Kanepe I, Narvaiss N, Patetko L, Kalnins G, Sisovs M, Bula AL, Grinberga S, Boroduskis M, Ramata-Stunda A,
et al. Discovery of SARS-CoV-2 Nsp14 and Nsp16 Methyltransferase Inhibitors by High-Throughput Virtual Screening. Pharmaceuticals. 2021; 14(12):1243.
https://doi.org/10.3390/ph14121243
Chicago/Turabian Style
Bobrovs, Raitis, Iveta Kanepe, Nauris Narvaiss, Liene Patetko, Gints Kalnins, Mihails Sisovs, Anna L. Bula, Solveiga Grinberga, Martins Boroduskis, Anna Ramata-Stunda,
and et al. 2021. "Discovery of SARS-CoV-2 Nsp14 and Nsp16 Methyltransferase Inhibitors by High-Throughput Virtual Screening" Pharmaceuticals 14, no. 12: 1243.
https://doi.org/10.3390/ph14121243
APA Style
Bobrovs, R., Kanepe, I., Narvaiss, N., Patetko, L., Kalnins, G., Sisovs, M., Bula, A. L., Grinberga, S., Boroduskis, M., Ramata-Stunda, A., Rostoks, N., Jirgensons, A., Tars, K., & Jaudzems, K.
(2021). Discovery of SARS-CoV-2 Nsp14 and Nsp16 Methyltransferase Inhibitors by High-Throughput Virtual Screening. Pharmaceuticals, 14(12), 1243.
https://doi.org/10.3390/ph14121243